A comprehensive view of Combination Therapy. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Immutep in second oncology trial with Merck KGaA and Pfizer for new combination study of its eftilagimod alpha LAG-3 candidate with avelumab to take place in Germany; study to evaluate drug combination’s safety, efficacy in cancer patients

Intellectual Property India Publishes Patent Application for 'Combination Therapy For Treating A Hematological Malignancy' Filed by Astrazeneca Ab

Roche receives Canadian approval for injectable Polivy polatuzumab vedotin to treat B-cell lymphoma; drug used in combination with Rituxan rituximab, cyclophosphamide, doxorubicin and immunosuppressive drug prednisone

INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "DOSING REGIMEN FOR COMBINATION THERAPY TARGETING DLL3 AND PD-1"

AstraZeneca reports three new cancer drugs recommended for approval in EU; drugs include Imfinzi/chemotherapy combo treatment for biliary tract cancer, gastric cancer drug Enhertu, prostate cancer treatment Lynparza in combination with Abiraterone

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count